EGFR and nasopharyngeal carcinoma: In terms of survival analysis: NPC patients with higher EGFR levels (Fig. 6C, P = 0.022), decreased MHC-I (Fig. 6D, P = 0.005), or reduced CD8+T cell infiltration (Fig. 6E, P = 0.003) had shorter survival spans.